share_log

Deere, Amgen, Copart And More: CNBC's 'Final Trades'

Benzinga ·  Oct 10 20:49

On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Deere & Company (NYSE:DE) as his final trade.

On Wednesday, Citigroup analyst Kyle Menges maintained Deere with a Neutral and raised the price target from $395 to $420.

Jason Snipe of Odyssey Capital Advisors said Amgen Inc. (NASDAQ:AMGN) has got a really strong pipeline.

On Monday, Barclays analyst Carter Gould maintained Amgen with an Equal-Weight rating and raised the price target from $300 to $315.

Don't forget to check out our premarket coverage here

Shannon Saccocia of NB Private Wealth named iShares U.S. Healthcare ETF (NYSE:IYH).

Joseph M. Terranova of Virtus Investment Partners picked Copart, Inc. (NASDAQ:CPRT), an industrial name.

On Sept. 4, Copart reported quarterly earnings of 33 cents per share, which missed the analyst consensus estimate by 8.33%. Quarterly revenue came in at $1.068 billion, which missed the analyst consensus estimate of $1.081 billion. Gross profit and net income were $454 million and $323 million, respectively.

Price Action:

  • Deere gained 1.3% to close at $405.48 during Wednesday's session.
  • Amgen shares gained 1.5% to close at $322.41 on Wednesday.
  • iShares U.S. Healthcare ETF gained 1% during Wednesday's session.
  • Copart shares gained 2.6% to settle at $55.84 on Wednesday.
  • S&P Settles At Record High As Apple, Amazon Shares Surge: Investor Optimism Improves Ahead Of Inflation Data

Image: Shutterstock

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment